Journal Club

ページタイトル画像
2026/03/02
Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis (Evolut low risk trial) 〜自己拡張型弁によるTAVR VS SAVRの術後6年間の臨床成績〜

2026/02/16
Does adding a delayed phase to cardiac computed tomography for coronary artery evaluation have prognostic value? 　心臓CTによる冠動脈評価において遅延相を追加することが予後予測に有用か

2026/02/09
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial　多枝病変を有するSTEMI患者において、完全血行再建を即時に行うもしくは入院中に行う戦略の比較

2026/02/02
CT-derived extracellular volume fraction in aortic stenosis, cardiac amyloidosis, and dual pathology 大動脈弁狭窄症 (AS)、トランスサイレチン型心アミロイドーシス (ATTR-CA)、および併存症例におけるCT由来細胞外容積分画 (CT-ECV） ～CT-ECVはASを合併したATTRの鑑別する有用なツールとなりうるか？～

2026/01/26
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial　心房細動のリズムコントロール後に左室機能が回復した症例における心不全治療薬中止：WITHDRAW-AF試験

2026/01/19
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction 左室駆出率が正常な心筋梗塞後の患者にβ遮断薬は有用か？ 〜5つの臨床試験のメタ解析から〜

2026/01/05
Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction - iMODERN trial － STEMI患者の非責任病変に対するPCIはどのタイミングが望ましいか？－

2025/12/22
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial 多量血栓を伴うSTEMIに対する低用量アルテプラーゼの投与は有効か？

2025/12/15
Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries TEERは心房性機能性僧帽弁閉鎖不全症 (AFMR)の予後を改善させ得る

2025/12/08
10-year outcome of deferred of conventional stent implantation in patients with STEMI(DANAMI-3-DEFFER)　 −ST上昇型急性心筋梗塞における待機的 vs即時ステント留置の10年臨床成績−

2025/12/01
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1) , in patients with intermittent claudication (SWEDEPAD 2)　 ― 大腿膝窩動脈治療における薬剤デバイスの役割とは ―

2025/11/17
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years (PARTNER 3 trial)

2025/11/10
NEMESIS-PFA: Investigating Collateral Tissue Injury Associated With Pulsed Field Ablation　心房細動患者におけるパルスフィールドアブレーションによる非標的組織の障害〜NEMESIS-PFA研究〜

2025/10/27
Clinical Outcomes of Conduction System Pacing vs Right Ventricular Septal Pacing in Atrioventricular Block ~ The CSPACE Randomized Controlled Trial ~

2025/10/23
Extent and Features of Late Gadolinium Enhancement Stratify Arrhythmic Risk in Patients With Biopsy-Proven Sarcoidosis サルコイドーシス患者における心臓MRIでの遅延造影を用いた不整脈リスクの新しい層別化

2025/10/06
Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation - Is It Time to Change the Guidelines? – 無症候性⼤動脈弁閉鎖不全症における早期左⼼室機能障害の⼼エコー指標

2025/09/29
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial

2025/09/22
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis 酸化型sGCの再活性化による大動脈弁狭窄症進行抑制の新たな治療戦略

2025/09/08
Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome: Results of the Multicenter GEIST Registry. たこつぼ症候群におけるβ遮断薬の内服が長期予後に与える影響

2025/09/01
Usefulness of Aortic Valve Calcification in Patients With Low-Flow Aortic Stenosis 低流量性大動脈弁狭窄症症例における大動脈弁石灰化評価の有用性